Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Research article

Clinical characteristics and outcomes of the oldest old people with type 2 diabetes – perspective from a tertiary diabetes center in Thailand

Authors: Thewjitcharoen Yotsapon, Krittiyawong Sirinate, Wanothayaroj Ekgaluck, Vongterapak Somboon, Anuntakulnatee Tawee, Kittipoom Worawit, Nakasatien Soontaree, Himathongkam Thep

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Abstract

Background

Advance in medicine has led to an increase in life expectancy of elderly diabetic patients especially on the growing population called the “oldest old”, those in their mid-80s upwards. The aim of this study is to describe clinical characteristics and outcomes of “oldest old” patients in a specialized diabetes center.

Methods

A retrospective review was conducted on medical records of type 2 diabetes who were older than 85 years at Theptarin hospital from September 2014 to August 2015.

Results

During the study period, there were 143 oldest old diabetic patients who visited our hospital regularly. Of the 133 active follow-up patients (median time of follow-up 15 years, range 1–30 years), 70.7 % was female, the mean age of onset was 68.3 ± 11.5 years and duration of diabetes was 20.1 ± 11.1 years. According to the Charlson co-morbidity index (CCI), 35.3 % of patients were classified as having severe co-morbidities. The mean A1C, blood pressure, LDL were 6.7 ± 1.1 %, 132/65 mmHg and 80 ± 29 mg/dl respectively. 66.9 % of patients had tight glycemic control (A1C <7 %) while 12.0 % had poor control (A1C >8 %). Oral hypoglycemic agent (OHA) dual therapy was the most common treatment (26.3 %) followed by OHA monotherapy (22.6 %), insulin alone (19.5 %), diet therapy alone (12.7 %), and insulin plus OHA (8.3 %). Hypoglycemia was found in 10.5 % of patients in previous 12 months. Diabetic retinopathy, chronic kidney disease, cardiovascular disease, and stroke were presented in 23.4, 54.9, 15.8, 18.0 % of patients, respectively. Among patients whose received diabetic medications and resulted in very low level of A1C (A1C less than 6.0 %), only 20.0 % underwent deintensification.

Conclusions

Our results revealed that real-world clinical outcomes of extreme elderly diabetic patients were diverse and being too “aggressive” diabetes treatment with older patients did occur frequently. Decision making in older people with diabetes is complex as chronic co-morbidities are very common.
Literature
3.
go back to reference Cornoni-Huntley JC, Foley DJ, White LR, Suzman R, Berkman LF, Evans DA, et al. Epidemiology of disability in the oldest old: methodological issues and preliminary findings. Milbank Mem Fund Q Health Soc. 1985;63:350–76.CrossRefPubMed Cornoni-Huntley JC, Foley DJ, White LR, Suzman R, Berkman LF, Evans DA, et al. Epidemiology of disability in the oldest old: methodological issues and preliminary findings. Milbank Mem Fund Q Health Soc. 1985;63:350–76.CrossRefPubMed
7.
go back to reference Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174:251–8.CrossRefPubMedPubMedCentral Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174:251–8.CrossRefPubMedPubMedCentral
8.
go back to reference Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011;57:e253–62.PubMedPubMedCentral Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011;57:e253–62.PubMedPubMedCentral
9.
go back to reference Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.CrossRefPubMedPubMedCentral Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.CrossRefPubMedPubMedCentral
10.
go back to reference Sinclair A, Morley JE, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc. 2012;13:497–502.CrossRefPubMed Sinclair A, Morley JE, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc. 2012;13:497–502.CrossRefPubMed
12.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
14.
go back to reference Garfein AJ, Herzog AR. Robust aging among the young-old, old-old, and oldest-old. J Gerontol B Psychol Sci Soc Sci. 1995;50:S77–87.CrossRefPubMed Garfein AJ, Herzog AR. Robust aging among the young-old, old-old, and oldest-old. J Gerontol B Psychol Sci Soc Sci. 1995;50:S77–87.CrossRefPubMed
15.
go back to reference Meneilly GS. Pathophysiology of type 2 diabetes in the elderly. Clin Geriatr Med. 1999;15:239–53.PubMed Meneilly GS. Pathophysiology of type 2 diabetes in the elderly. Clin Geriatr Med. 1999;15:239–53.PubMed
16.
go back to reference Motta M, Bennati E, Capri M, Ferlito L, Malaguarnera M. Diabetes mellitus in the extreme longevity. Exp Gerontol. 2008;43:102–5.CrossRefPubMed Motta M, Bennati E, Capri M, Ferlito L, Malaguarnera M. Diabetes mellitus in the extreme longevity. Exp Gerontol. 2008;43:102–5.CrossRefPubMed
17.
go back to reference Cahn A, Raz I, Kleinman Y, Balicer R, Hoshen M, Lieberman N, et al. Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists. Diabetes Care. 2015;38:2293–300.CrossRefPubMedPubMedCentral Cahn A, Raz I, Kleinman Y, Balicer R, Hoshen M, Lieberman N, et al. Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists. Diabetes Care. 2015;38:2293–300.CrossRefPubMedPubMedCentral
18.
go back to reference Weber P, Meluzínova H, Kubesova H, Polcarova V, Kocourhova B, Striova A, et al. Insulin treatment in diabetics 75+ years: experiences and results in outpatient care. Adv Gerontol. 2008;21:143–7.PubMed Weber P, Meluzínova H, Kubesova H, Polcarova V, Kocourhova B, Striova A, et al. Insulin treatment in diabetics 75+ years: experiences and results in outpatient care. Adv Gerontol. 2008;21:143–7.PubMed
19.
go back to reference Zhang L, Ji L, Guo L, Lu J, Tian H, Zhu D, et al. Treatment patterns and glycemic control in older adults with type 2 diabetes mellitus receiving only oral antidiabetes drugs in China. Diabetes Technol Ther. 2015;17:816–24.CrossRefPubMed Zhang L, Ji L, Guo L, Lu J, Tian H, Zhu D, et al. Treatment patterns and glycemic control in older adults with type 2 diabetes mellitus receiving only oral antidiabetes drugs in China. Diabetes Technol Ther. 2015;17:816–24.CrossRefPubMed
20.
go back to reference Chan NN, Brain HP, Feher MD. Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med. 1999;16:273–81.CrossRefPubMed Chan NN, Brain HP, Feher MD. Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med. 1999;16:273–81.CrossRefPubMed
21.
go back to reference Mathieu C. Metformin-associated lactic acidosis: time to let it go? J Diabetes Complications. 2015;29:974–5.CrossRefPubMed Mathieu C. Metformin-associated lactic acidosis: time to let it go? J Diabetes Complications. 2015;29:974–5.CrossRefPubMed
22.
go back to reference Viljoen A, Meek C, Gadsby R, Viljoen S, Langerman H, Sinclair A. The tolerability and safety of DPP-4 inhibitors for the treatment of older people with type 2 diabetes mellitus: an observational study. Br J Diabetes Vasc Med. 2013;13:187–91.CrossRef Viljoen A, Meek C, Gadsby R, Viljoen S, Langerman H, Sinclair A. The tolerability and safety of DPP-4 inhibitors for the treatment of older people with type 2 diabetes mellitus: an observational study. Br J Diabetes Vasc Med. 2013;13:187–91.CrossRef
23.
go back to reference van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 2005;28:154–63.CrossRefPubMed van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 2005;28:154–63.CrossRefPubMed
24.
go back to reference Tseng YH, Tsan YT, Chan WC, Sheu WH, Chen PC. Use of an α-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: A nationwide, population-based cohort study. Diabetes Care. 2015;38:2068–74.CrossRefPubMed Tseng YH, Tsan YT, Chan WC, Sheu WH, Chen PC. Use of an α-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: A nationwide, population-based cohort study. Diabetes Care. 2015;38:2068–74.CrossRefPubMed
25.
go back to reference Weaver GA, Tangel CT, Krause JA, et al. Biomarkers of human colonic cell growth are influenced differently by a history of colonic neoplasia and the consumption of acarbose. J Nutr. 2000;130:2718–25.PubMed Weaver GA, Tangel CT, Krause JA, et al. Biomarkers of human colonic cell growth are influenced differently by a history of colonic neoplasia and the consumption of acarbose. J Nutr. 2000;130:2718–25.PubMed
26.
27.
go back to reference World Health Organization. Dementia: a public health priority. In: Book Dementia: A Public Health Priority. Geneva: WHO; 2012. p. 12–9. World Health Organization. Dementia: a public health priority. In: Book Dementia: A Public Health Priority. Geneva: WHO; 2012. p. 12–9.
28.
go back to reference Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175:1942–9.CrossRefPubMed Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175:1942–9.CrossRefPubMed
29.
go back to reference Xin L, Zhaoyan W. Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Exp Ther Med. 2013;5:1393–6. Xin L, Zhaoyan W. Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Exp Ther Med. 2013;5:1393–6.
30.
go back to reference Katherine T, George B, Rudolf B, Jane C, Ian B, Jordi GF, Irl H, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864–83.CrossRef Katherine T, George B, Rudolf B, Jane C, Ian B, Jordi GF, Irl H, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864–83.CrossRef
31.
go back to reference von Faber M, Bootsma-van der Wiel A, van Exel E, Gussekloo J, Lagaay AM, van Dongen E, et al. Successful aging in the oldest old: who can be characterized as successfully aged? Arch Intern Med. 2001;161:2694–70.CrossRef von Faber M, Bootsma-van der Wiel A, van Exel E, Gussekloo J, Lagaay AM, van Dongen E, et al. Successful aging in the oldest old: who can be characterized as successfully aged? Arch Intern Med. 2001;161:2694–70.CrossRef
Metadata
Title
Clinical characteristics and outcomes of the oldest old people with type 2 diabetes – perspective from a tertiary diabetes center in Thailand
Authors
Thewjitcharoen Yotsapon
Krittiyawong Sirinate
Wanothayaroj Ekgaluck
Vongterapak Somboon
Anuntakulnatee Tawee
Kittipoom Worawit
Nakasatien Soontaree
Himathongkam Thep
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0115-9

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue